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Synthetic Studies towards Communesins: Diastereoselective 
Oxidative Rearrangement of Aurantioclavine Derivatives 
Satoshi Suetsugu, Chihiro Tsukano and Yoshiji Takemoto*[a] 
Abstract: Communesins are a heptacyclic class of indole alkaloids 
bearing two aminal moieties and two contiguous quaternary carbon 
centers. We have investigated the construction of the pentacyclic 
skeleton of communesins via the oxidative rearrangement of 
aurantioclavine derivatives, because aurantioclavine is believed to 
be a biosynthetic intermediate of the polycyclic communesin 
alkaloids. The C7 quaternary carbon center was constructed in a 
stereoselective manner, while the installation of the C11 
stereocenter required an epimerization process. The isolation of 2-
ethoxyindolenine prior to the reduction of the nitro group and 
cyclization was found to be critical to the success of this strategy. 
Introduction 
Communesins are a heptacyclic class of indole alkaloids bearing 
two aminal moieties and two contiguous quaternary carbon 
centers that can isolated from a marine fungal strain of 
Penicillium species (Figure 1).1,2 These alkaloids have been 
reported to show significant cytotoxicity against P388 
lymphocytic leukemia cells (A, B: ED50 = 3.5 and 0.45 g/mL 
respectively), as well as potent insecticidal activity towards 
silkworms (B, E: LD50 = 5 and 80 g/g). These molecules have 
also attracted considerable interest as synthetic targets because 
of their complex structures and significant biological activities.3 
Several total syntheses have been reported to date for the 
construction of racemic communesins, including those of Qin4, 
Weinreb5, Ma6a and Funk.7 Furthermore, Ma et al.6b also 
reported the development of an asymmetric total synthesis of 
communesins. Interestingly, Stoltz and co-workers reported that 
aurantioclavine, which is a tricyclic alkaloid isolated from 
Penicillium aurantiovirens,8 could be a biosynthetic intermediate 
of the polycyclic communesin alkaloids.9,10 In a separate study, 
Stoltz et al,11 reported a formal synthesis of (±)-communesin F 
using a unified stereodivergent alkylation approach, as well as a 
biosynthesis-inspired approach from aurantioclavine. Tang et 
al.12 confirmed that communesins can biosynthesized by the 
coupling of tryptamine and aurantioclavine based on a series of 
genetic-inactivation studies.12 
We recently reported the development of an 
enantioselective total synthesis of aurantioclavine based on a 
Pd-catalyzed asymmetric allylic amination reaction.13 Given that 
communesins share their core structure with aurantioclavine, it 
was envisaged that our recently developed route could be 
applied to the asymmetric synthesis of communesins. 
Furthermore, if we could achieve the synthesis of communesins 
from intermediate 6 for aurantioclavine, then it would possible to 
prepare a wide range of synthetic analogs for biological studies 
using the same synthetic route. With this in mind, we 
investigated the possibility of extended of our previous 
methodology to the construction of communesins. 
 
 
Figure 1. Communesins and (−)-Aurantioclavine. 
It was envisioned that the communesins could be synthesized 
from pentacyclic compound 1 bearing a C7 quaternary carbon 
center. Compound 1 itself could be prepared from 6 via one of 
two different synthetic routes (Scheme 1). According to the first 
of these two routes, pentacyclic skeleton 1 could be constructed 
by the Pd-catalyzed cyclization14 of amidine 2, which could itself 
be constructed by the SmI2-mediated reductive cyclization15 of 
carbodiimide 3 (route A). It is noteworthy that SmI2-mediated 
reductive cyclization reactions of this type represent a powerful 
and reliable strategy for the synthesis of 2-iminoindolines. The 
second potential strategy for the construction of compound 1 
involved the oxidative rearrangement of the 2-substituted indole 
5, which contains the same skeleton as aurantioclavine, to give 
4. The subsequent cyclization of 4 would then give the desired 
pentacyclic compound 1 (route B). The use of an oxidative 
rearrangement reaction for the synthesis of 3,3-disubstituted 
oxindoles is a well established method in organic chemistry, and 
this strategy has been used before for the construction of an 
indole alkaloid.16 Notably, the two important intermediates 3 and 
5 could be derived from common intermediate 6, which we 
prepared previously in our synthesis of (–)-aurantioclavine. In 
this study, we describe our efforts towards the synthesis of the 
pentacyclic skeleton 1 based on the two synthetic routes 
described above. The isolation of 2-ethoxylindolenine from the 
oxidative rearrangement reaction was found to be critical to the 
success of this strategy, because it prevented the occurrence of 
any undesired side reactions. 
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Scheme 1. Retrosynthesis of the pentacyclic core of Communesins. 
Results and Discussion 
We initially investigated the synthesis of carbodiimide 313 to 
explore the feasibility of using sequential SmI2-mediated 
reductive cyclization and Pd-catalyzed cyclization reactions. The 
reduction of the nitro group in azepane 617 gave aniline 7 
(Scheme 2). The subsequent treatment of 7 with o-BrC6H4NCO 
gave the corresponding urea, which was converted to 
carbodiimide 3 following a dehydration reaction with CBr4 and 
PPh3. The amidine core bearing the desired quaternary carbon 
center was successfully constructed using a SmI2-mediated 
reductive cyclization reaction.14 Disappointingly, however, the 
C7 stereochemistry was the undesired configuration. The 
formation of the undesired stereochemistry at C7 can be 
explained in terms of the differences in the stabilities of the 
different conformers of compound 3 (Figure 2). Conformer A 
would be thermodynamically more stable than conformer B 
because the Ts and vinyl groups would be axial, which would 
minimize the steric repulsion between these two groups. With 
this in mind, the reaction would proceed through conformer A to 
give cyclized compound 8.18 The subsequent Boc protection of 
the indoline nitrogen gave compound 9 as a single diastereomer, 
and both of these compounds were screened against an 
extensive series of Pd-catalyzed conditions in an attempt to 
affect their cyclization to give the desired pentacyclic compound 
10.14 However, none of the conditions tested provided access to 
compound 10. For example, the treatment of 9 with Pd(OAc)2, 
PPh3 and Cs2CO3 in toluene at 80 °C gave a complex mixture. 
Furthermore, the use of other ligands19 and bases20 also 
resulted in the decomposition of the starting material. Given that 
the  position of the ester would be congested under the 
conditions required of Pd-mediated catalysis, it would be difficult 
for the Pd-intermediate derived from the oxidative addition of the 
aryl bromide to Pd(0) to react with the enolate. With this in mind, 
we switched our focus the second of the two plans described 
above (i.e. route B, Scheme 1), where the fifth ring would be 
cyclized via the formation of an amidine.5,8 
 
Scheme 2. Attempted formation of the amidine ring by a Pd-catalyzed 
cyclization. 
 
Figure 2. Stereochemistry of SmI2-mediated reductive cyclization of 3. 
To evaluate the feasibility of the second strategy, we prepared 
several 2-substituted indoles for the oxidative rearrangement 
reaction. The treatment of compound 6 with P(OEt)3 at 170 °C 
gave ester 5a, which was subjected to a hydrolysis reaction 
followed by a condensation reaction with N-
methoxymethylamine to give Weinreb amide 5c (Scheme 3). 
The subsequent reduction of 5a with DIBAL-H, followed by the 
allylic oxidation of the resulting alcohol gave aldehyde 5b. The 
nucleophilic addition of an in situ generated Grignard reagent to 
the aldehyde gave the corresponding alcohol 11, which was 
treated with MnO2 to give ketone 5d. Compound 12 was also 






prepared from alcohol 11 to determine the importance of the 
carbonyl group. 
 
Scheme 3. Synthesis of substrates 5a–d and 12 for the oxidative 
rearrangement. 
With a series of 2-substituted indoles in hand (5a–d and 12), we 
proceeded to investigate the oxidative rearrangement of these 
compounds for the synthesis of oxindoles bearing a quaternary 
carbon center at C7. The chlorination of ester 5a with tBuOCl, 
followed by the treatment of the resulting species with 1 M HCl 
in EtOH-CH2Cl2 gave the desired oxindole 4a (Table 1, entry 1). 
Although the reaction of aldehyde 5b under the same conditions 
gave oxindole 13 instead of the desired compound 4b, Weinreb 
amide 5c was converted to 4c in 62% yield (Table 1, entries 2 
and 3). These results were consistent with the results reported 
by Moody.16a Compound 13 was most likely produced by the 
retro-Claisen-type reaction of 4b following its oxidative 
rearrangement. Ketone 5d reacted smoothly under these 
conditions to give the desired compound 4d. In contrast, the 
reaction of 12, which did not contain a carbonyl group, gave a 
complex mixture of products (Table 1, entries 4 and 5). These 
results therefore indicated that the presence of a carbonyl group 








Table 1. Oxidative rearrangement of compounds 5a–d and 12.  
 
Entry Substrate R Results[a]  
1 5a -CO2iPr 4a (54%)  
2 5b -CHO 4b (0%), 13 (80%)  
3 5c -CONMe(OMe) 4c (62%)  
4 5d  4d (88%)  
5 12  Complex mixture  
[a] Isolated yield. 
 
We then attempted to access a cyclized precursor from 
compounds 4c and 4d (Scheme 4). The protection of the indole 
nitrogen in 4c with a methyl group gave compound 14, which 
was treated with an in situ-generated aryl lithium reagent 
prepared from iodide 15 and tBuLi in an attempt to prepare 
compound 16. However, this reaction resulted in the 
decomposition of the substrate. The reaction of 4d with zinc in 
acetic acid led to the reduction of the nitro group followed by the 
cleavage of the C–C bond at the 3-position of the oxindole core 
to give compound 13. The cleavage of the C–C bond was 
attributed to the delocalization of the electron pair of the newly 
formed aniline 19.21 Furthermore, the reduction of ketone 17, 
which was prepared from 4d, also gave product 13 via a similar 
retro-aldol-type reaction through compound 20. Based on these 
results, we concluded that the oxindole moiety was the cause of 
the undesired retro-aldol-type reactions, and that it would 
therefore need to be protected prior to the reduction of nitro and 
carbonyl groups. 







Scheme 4. Attempted derivatization of 4c and 4d. 
To address the issues described above, we selected 2-
alkoxyindolenine, which is an intermediate of the oxidative 
rearrangement reaction, as a suitable protecting group for the 
reduction of the nitro group. Given that 2-ethoxyindolenine 21 
was not isolated during the course of our initial evaluation of the 
oxidative rearrangement reaction, as shown in Table 1, it was 
anticipated that this compound would be unstable under the 
reaction conditions or its subsequent purification by column 
chromatography over silica gel. With this in mind, the reduction 
of 21 was performed immediately after its formation and 
concentration without any further purification. Although the 
reduction of 21 with SnCl2 in toluene gave a complex mixture, 
the use of Zn gave compounds 13 and 2322 in 54 and 14% 
yields, respectively (Table 2, entries 1 and 2). When the 
reduction was conducted in the presence of Fe, the reaction 
gave a small amount of 23 as part of a complex mixture (Table 2, 
entry 3). When isopropanol was used instead of ethanol to 
stabilize the 2-alkoxyindolenine intermediate, 2-
isopropoxyindolenine was obtained as an intermediate. However, 
the oxidative rearrangement of this intermediate did not proceed 
smoothly, and the subsequent treatment of this material with Zn 
gave a complex mixture (Table 2, entry 4). The reduction was 
also conducted without the concentration of the 2-
ethoxyindolenine solution, but gave only compound 23 in 47% 
yield (Table 2, entry 5). We speculated that the by-product 23 
would be produced by the formation of the pentacyclic skeleton 
22, followed by a retro-Claisen-type reaction and the formation 
of an indoloquinazolinone (Scheme 5). In fact, compound 22 
was observed in the 1H NMR spectrum of a crude reaction 
mixture when a shorter reaction time was used. Furthermore, it 
was possible to isolate this material together with 2-
ethoxyindolenine 21 by silica gel column chromatography in low 
yields of 21 and 28%, respectively (Table 2, entry 6). After the 
isolation of 21, it was also confirmed that 21 could be readily 




Table 2. Investigation of the construction of the pentacyclic skeleton.  
 
Entry R Conditions Results[b]  
1 Et SnCl2, toluene, 70 °C, 2 h Complex mixture  
2 Et Zn, AcOH, toluene, 85 °C, 2 h 13 (54%), 23 (14%)  
3 Et Fe, AcOH, toluene, 85 °C, 2 h 23 (<15%)  
4 iPr Zn, AcOH, toluene, 85 °C, 2 h Complex mixture  
5 [a] Et Zn, H2O, 90 °C, 3 h 23 (47%)  
6 [a] Et Fe, H2O, 90 °C, 45 min 13 (16%), 23 (11%), 
21 (28%), 22 (21%) 
 
[a] Conc. HCl was used for the first step and the solvent was not evaporated 
before the reduction. [b] Isolated yield. 
 







Scheme 5. Conversion of 2-ethoxyindolenine 21 to indoloquinazolinone 23. 
Finally, we successfully isolated 2-ethoxyindolenine 21 in 98% 
yield by the treatment of 5d with tBuOCl followed by conc. HCl in 
EtOH. The subsequent reaction of 21 under mildly acidic 
conditions (i.e., Fe and solid NH4Cl in EtOH-H2O at 90 °C) gave 
the pentacyclic compound 22 in 43% yield without the formation 
of any of the undesired indoloquinazoline 23 (Scheme 6). The 
stereochemistry at C7 was determined after the Boc protection 
and subsequent reduction of the amidine nitrogen to give 26. 
The NOESY spectra of 26 revealed that Ha was correlated with 
Hb and Hc, and that Hd was correlated with He and Hf (Figure 3). 
These results therefore indicated that the C7 stereochemistry 
was R, and that the epimerization of C11 would be required for 
the construction of the communesin core.23 
 
Scheme 6. Synthesis of the pentacyclic skeleton 22. 
 
Figure 3. NOESY experiments with compound 26. 
Based on the results of several previous reports,16b,c,f,i-l the 
diastereoselectivity of the oxidative rearrangement can be 
rationalized as follows. The treatment of 5d with tBuOCl would 
give 3-chloroindolenine C, which would be thermodynamically 
more stable than D (Scheme 7). The protonation of C and 
formation of chloronium cation E would be followed by the 
addition of EtOH to give intermediate F. In this case, the 
rearrangement would occur via an SN1 reaction rather than an 
SN2 reaction. The elimination of the chloride ion and the 
diastereoselective rearrangement of the carboaryl moiety would 
therefore proceed through intermediate G to give 2-
ethoxyindolenine 21. 
 
Scheme 7. Stereochemistry of oxidative rearrangement of 5d. 
Conclusions 
We have investigated the construction of the pentacyclic 
skeleton of the communesins through two synthetic strategies, 
including i) a SmI2-mediated reductive cyclization and Pd-






catalyzed cyclization strategy; and ii) an oxidative 
rearrangement strategy. Although the first of these two 
strategies was found to be unsuccessful, the desired pentacyclic 
skeleton was successfully constructed using the second strategy. 
The C7 quaternary carbon center was constructed in a 
stereoselective manner based on an oxidative rearrangement 
reaction, while the C11 stereocenter required an epimerization 
step to afford the desired stereochemistry. Finally, the isolation 
of 2-ethoxyindolenine prior to the reduction of its nitro group was 
found to be critical to the success of the cyclization reaction. We 
are currently investigating the epimerization of the C11 carbon 
center with the aim of developing an enantioselective total 
synthesis of the communesins. 
Experimental Section 
General: All of the non-aqueous reactions were carried out under a 
positive atmosphere of argon in dried glassware. Analytical thin-layer 
chromatography was performed with Silica gel 60 (Merck). Silica gel 
column chromatography was performed over Kanto silica gel 60 (particle 
size, 63–210 m) and Fuji silysia Chromatorex BW-300. Proton nuclear 
magnetic resonance (1H NMR) spectra were recorded on a JEOL JNM-
ECA 500 system (JEOL, Japan) at 500 MHz or a JEOL JNM-AL 400 
system at 400 MHz. Chemical shifts have been reported relative to Me4Si 
( 0.00) in CDCl3. The multiplicities of the signals in the spectra have 
been described by one or more of the following: s (singlet); d (doublet); t 
(triplet); q (quartet); m (multiplet); br (broad). Carbon nuclear magnetic 
resonance (13C NMR) spectra were recorded on a JEOL JNM-ECA 500 
system at 126 MHz or a JEOL JNM-AL 400 system at 100 MHz. 
Chemical shifts have been reported relative to CDCl3 ( 77.0). Infrared 
spectra were recorded on a FT/IR-4100 Fourier-transform infrared 
spectrometer with attenuated total reflectance (JASCO, Japan). Low and 
High resolution mass spectra were recorded on JEOL JMS-HX/HX 110A 
mass spectrometer for FAB-MS and a Shimadzu LCMS-IT-TOF 
(Shimadzu, Japan) for ESI-MS. 
Material: Anhydrous CH2Cl2, THF, methanol and ethanol were 
purchased from KANTO Chemical Co. Aldrich and Wako chemicals. The 
reagents and materials used in the current study were obtained from 
Tokyo Chemical Industry Co., Ltd, Aldrich Inc. and several other 
commercial suppliers and used without further purification. 
Compound 5a: A solution of 6 (792 mg, 1.69 mmol) in P(OEt)3 (4.0 mL) 
was stirred at 170 °C for 3 h. The mixture was then concentrated under 
reduced pressure and purified by flash column chromatography over 
neutral silica gel (20% EtOAc/hexane) to give 5a (633 mg, 85%) as a 
colorless oil: [α]D21 –51.7 ° (c 1.12, CHCl3); 1H NMR (500 MHz, CDCl3)  
9.04 (1H, br s), 7.69 (2H, d, J = 8.3 Hz), 7.27-7.26 (1H, m), 7.20 (1H, t, J 
= 7.7 Hz), 7.15 (2H, d, J = 8.0 Hz), 6.84 (1H, d, J = 7.2 Hz), 6.04 (1H, s), 
5.77 (1H, ddd, J = 17.1, 10.4, 4.5 Hz), 5.30-5.25 (1H, m), 5.13 (1H, d, J = 
10.3 Hz), 4.68 (1H, d, J = 17.3 Hz), 4.05-4.03 (1H, m), 3.60-3.54 (2H, m), 
3.44-3.37 (1H, m), 2.34 (3H, s), 1.39 (3H, d, J = 2.6 Hz), 1.38 (3H, d, J = 
2.6 Hz). 13C NMR (126 MHz, CDCl3)  161.7, 142.9, 138.0, 137.7, 136.8, 
134.0, 129.3, 126.9, 125.2, 124.5, 123.2, 121.6, 120.2, 119.1, 110.6, 
68.5, 63.8, 43.2, 29.8, 22.0 (x2), 21.3; IR (ATR, cm-1) 3344, 2980, 1693, 
1452, 1338, 1248, 1156, 1094, 916, 751; HRMS (ESI) calcd for 
C24H27N2O4S [M+H]+ 439.1686; Found: m/z 439.1668. 
Compound 5b : To a solution of 5a (200 mg, 0.456 mmol) in CH2Cl2 (5 
mL) was added DIBAL-H (1 M in hexane, 1.6 ml, 1.6 mmol) at −78 °C, 
and the mixture was stirred at −78 °C for 1 h. The reaction mixture was 
then quenched with satd. aq. Na/K tartrate and stirred vigorously at room 
temperature for 1 h. The mixture extracted with EtOAc, washed with 
brine and dried over Na2SO4. Concentration under reduced pressure 
gave the crude alcohol without purification. To a solution of the crude 
alcohol in CHCl3 (20 mL) was added MnO2 (705 mg, 8.11 mmol) at room 
temperature, and the mixture was stirred at 40 °C for 1 h. After reaction 
mixture was filtered through a pad of Celite, and concentration under 
reduced pressure. The crude material was purified by flash column 
chromatography on silica gel (30 % EtOAc/hexane) to give 5b (124 mg, 
76%, 2 steps) as a white amorphous: [α]D22 –42.8 ° (c 0.66, CHCl3); 1H 
NMR (CDCl3)  9.94 (1H, s), 8.94 (1H, br s), 7.69 (2H, d, J = 6.9 Hz), 
7.30-7.28 (2H, m), 7.19 (2H, d, J = 7.4 Hz), 6.90-6.89 (1H, m), 6.06 (1H, 
br s), 5.79-5.75 (1H, m), 5.16 (1H, d, J = 10.3 Hz), 4.67 (1H, d, J = 17.2 
Hz), 4.11-4.08 (1H, m), 3.65 (1H, td, J = 10.2, 5.1 Hz), 3.53-3.49 (2H, m), 
2.37 (3H, s); 13C NMR (126 MHz, CDCl3)  180.3, 143.2, 138.4, 137.9, 
137.4, 135.4, 131.3, 129.5, 127.0, 126.8, 126.2, 125.2, 120.8, 119.6, 
111.2, 63.6, 43.0, 27.6, 21.5; IR (film, cm-1) 3317, 2981, 2918, 1649, 
1574, 1535, 1460, 1369, 1341, 1278, 1236, 1158, 1092, 1019, 974, 915, 
876, 755, 736, 691, 667; HRMS (FAB) calcd for C21H21N2O3S [M+H] + 
381.1273; Found: m/z 381.1272. 
Compound 5c: To a solutions of 5a (150 mg, 0.379 mmol) in MeOH (4 
mL) and THF (4 mL) was added a solutions of 2M aq. NaOH (4 mL). The 
mixture was refluxed for 1 h, and then concentration under reduced 
pressure until THF and MeOH were removed. The residue was acidified 
with 2M aq. HCl (4 mL) and extracted with EtOAc, dried over Na2SO4. 
After concentration under reduced pressure, a crude carboxylic acid was 
obtained as a white solid. To a solution of crude in THF (8 mL) was 
added NHMe(OMe) (56 mg, 0.568 mmol), EDCI (109 mg, 0.568 mmol), 
HOBt (77mg, 0.568 mmol) and Et3N (0.159 mL, 1.14 mmol) at room 
temperature. This mixture was stirred at room temperature for 5 h. The 
reaction mixture was concentrated under reduced pressure and purified 
by flash column chromatography on silica gel (30% EtOAc/hexane) to 
give the mixture of 5c (156 mg, 94 %) as a white amorphous: [α]D22 –
39.4 ° (c 0.27, CHCl3); 1H NMR (500 MHz, CDCl3)   9.19 (1H, br s), 7.68 
(2H, d, J = 8.3 Hz), 7.26-7.21 (2H, m), 7.14 (2H, d, J = 8.0 Hz), 6.88 (1H, 
d, J = 6.9 Hz), 6.09 (1H, s), 5.84-5.81 (1H, m), 5.14 (1H, d, J = 10.3 Hz), 
4.71 (1H, d, J = 16.9 Hz), 4.01 (1H, d, J = 14.9 Hz), 3.68 (3H, s), 3.63-
3.53 (2H, m), 3.41-3.34 (4H, m), 2.34 (3H, s); 13C NMR (126 MHz, 
CDCl3)  161.9, 142.7, 138.2, 138.0, 136.4, 133.8, 129.5, 129.3, 127.0, 
124.7, 124.2, 123.7, 122.5, 120.2, 119.0, 110.5, 63.8, 61.8, 43.6, 33.3, 
29.5, 21.4; IR (ATR, cm-1) 3375, 2932, 1732, 1633, 1445, 1338, 1240, 
1156, 1094; HRMS (ESI) calcd for C23H26N3O4S [M+H]+ 440.1654; 
Found: m/z 440.1639. 
Compound 11: To a solution of 2-iodo-nitrobenzene (288 mg, 1.16 
mmol) in dry THF (3 mL) was added PhMgCl (2 M in toluene, 0.607 mL, 
1.22 mmol) at −40 °C, and the mixture was stirred at −40 °C for 15 min. 
The red mixture was then added the solution 5b (200 mg, 0.526 mmol) in 
THF (3 mL) at −40 °C and stirred at room temperature for 30 min. The 
reaction mixture was then quenched with satd. aq. NH4Cl, extracted with 
EtOAc, washed with water and brine, dried over Na2SO4. After 
concentration under reduced pressure, purification by flash column 
chromatography on silica gel (20% EtOAc/hexane) gave 11 (209 mg, 
79 %, a 1:1 diastereomeric mixture) as a pale yellow amorphous: 1H 
NMR (500 MHz, CDCl3)  8.67 (0.5 H, br s), 8.28 (0.5 H, br s), 7.99-7.97 
(1H, m), 7.66-7.58 (3H, m), 7.54-7.47 (1H, m), 7.28-7.27 (1H, m), 7.20-
7.07 (4H, m), 6.85-6.83 (1H, m), 6.49-6.47 (1H, m), 6.07-6.04 (1H, m), 
5.82-5.66 (1H, m), 5.13-5.08 (1H, m), 4.74 (0.5 H, d, J = 17.2 Hz), 4.63 
(0.5 H, d, J = 17.2 Hz), 3.94-3.91 (1H, m), 3.54-3.49 (2H, m), 3.10-3.07 
(1H, m), 2.74-2.66 (1H, m), 2.37-2.36 (3H, m); 13C NMR (126 MHz, 
CDCl3)  137.6, 134.1, 133.9, 132.3, 129.9, 129.5, 129.3, 129.2, 127.0 
(x2), 125.0, 121.6, 121.5, 119.8, 119.2, 119.0, 110.8, 110.0, 109.9, 65.4, 
64.1, 43.5, 28.3, 27.6, 21.4; IR (film, cm-1) 3414, 3027, 2942, 1598, 1526, 






1445, 1337, 1228, 1156, 1018, 790, 751, 666; HRMS (FAB) calcd for 
C27H25N3O5S [M]+ 503.1515; Found: m/z 503.1533. 
Compound 5d: To a solution of 11 (201 mg, 0.40 mmol) in CHCl3 (20 
mL) was added MnO2 (696 mg, 8.0 mmol) at room temperature, and the 
mixture was stirred at 40 °C for 1 h. After the reaction mixture was filtered 
through a pad of Celite, and concentration under reduced pressure. The 
crude material was purifed by flash column chromatography on silica gel 
(40% EtOAc/hexane) to give 5d (145 mg, 72%) as a yellow amorphous: 
[α]D22 –59.8 ° (c 0.44, CHCl3); 1H NMR (500 MHz, CDCl3)  9.16 (1H, s), 
8.26 (1H, d, J = 8.3 Hz), 7.81-7.78 (1H, m), 7.72-7.69 (1H, m), 7.55 (2H, 
d, J = 8.3 Hz), 7.42 (1H, d, J = 7.4 Hz), 7.28-7.26 (2H, m), 7.12 (2H, d, J 
= 8.3 Hz), 6.87-6.87 (1H, m), 6.01 (1H, s), 5.77-5.74 (1H, m), 5.15 (1H, d, 
J = 10.3 Hz), 4.71 (1H, d, J = 17.5 Hz), 3.78-3.75 (1H, m), 3.48-3.42 (1H, 
m), 2.77-2.73 (1H, m), 2.49-2.46 (1H, m), 2.34 (3H, s); 13C NMR (126 
MHz, CDCl3)  184.9, 145.2, 143.1, 138.0, 127.8, 127.5, 136.4, 135.2, 
124.7, 130.8, 130.3, 129.4, 128.1, 126.8, 126.3, 125.6, 125.0, 123.1, 
121.0, 119.5, 111.1, 63.7, 43.0, 29.3, 21.4; IR (film, cm-1) 3346, 3029, 
2946, 2861, 1633, 1572, 1525, 1446, 1415, 1343, 1273, 1251, 1156, 
1061, 1019, 992, 939, 852, 1019, 992, 939, 852, 789, 752, 704, 668; 
HRMS (FAB) calcd for C27H24N3O5S [M+H]+ 502.1437; Found: m/z 
502.1454.  
Compound 4a: To a solution of 5a (50 mg, 0.106 mmol) in CH2Cl2 (3 
mL) was added tBuOCl (0.018 ml, 0.159 mmol), and the mixture was 
stirred at room temperature for 1 h. Concentration under reduced 
pressure gave the crude material, and used the next reaction without 
purification. To the solution of the residue in EtOH (2 ml) and CH2Cl2 (3 
mL) was added HCl (1 M in Et2O, 0.10 ml), and the mixture was stirred at 
room temperature for 3 h. The reaction mixture was concentrated under 
reduced pressureand  purified by flash column chromatography on silica 
gel (20% EtOAc/hexane) to give 4a (26 mg, 54%) as a colorless oil: [α]D21 
–3.9 ° (c 1.28, CHCl3); 1H NMR (CDCl3)  8.33 (1H, s), 7.51 (2H, d, J = 
8.0 Hz), 7.23 (1H, t, J = 7.7 Hz), 7.16 (2H, d, J = 8.3 Hz), 6.93 (1H, d, J = 
7.7 Hz), 6.85 (1H, d, J = 7.7 Hz), 5.77-5.69 (2H, m), 5.21 (1H, d, J = 10.2 
Hz), 4.85-4.81 (2H, m), 4.09-4.06 (1H, m), 3.92-3.89 (1H, m), 2.51-2.49 
(1H, m), 2.36 (3H, s), 1.55-1.50 (1H, m), 1.12 (3H, d, J = 6.3 Hz), 1.05 
(3H, d, J = 6.3 Hz); 13C NMR (126 MHz, CDCl3)  175.5, 167.2, 143.2, 
142.2, 137.9, 137.8, 135.1, 129.5, 129.0, 126.9, 126.8, 123.6, 120.4, 
109.6, 70.1, 63.2, 59.3, 41.8, 29.7, 21.4, 21.1 (x2); IR (film, cm-1) 3302, 
2987, 2939, 1740, 1713, 1617, 1601, 1494, 1459, 1405, 1388, 1375, 
1330, 1304, 1266, 1215, 1157, 1122, 1038, 986, 943, 914, 874, 807; 
HRMS (FAB) calcd for C24H27N2O5S [M+H]+ 455.1641; Found: m/z 
455.1647.  
Compound 4c: 4c was obtained by following the procedure for 4a: [α]D21 
–8.7 ° (c 0.46, CHCl3); 1H NMR (CDCl3)  9.18 (1H, s), 7.45 (2H, t, J = 
8.0 Hz), 7.21 (1H, t, J = 7.7 Hz), 7.15 (2H, t, J = 6.4 Hz), 6.98 (1H, d, J = 
7.7 Hz), 6.87 (1H, d, J = 8.0 Hz), 5.89-5.87 (1H, m), 5.67 (1H, br s), 5.22 
(1H, d, J = 10.5 Hz), 5.06-5.02 (1H, m), 4.25 (1H, t, J = 13.6 Hz), 4.03 
(1H, d, J = 15.8 Hz), 3.02 (3H, s), 2.95 (3H, s), 2.48-2.45 (1H, m), 2.36 
(3H, s), 1.38-1.34 (1H, m); 13C NMR (126 MHz, CDCl3)  175.8, 169.0, 
143.1, 142.3, 138.5, 137.7, 134.7, 129.5, 128.7, 127.4, 126.8, 123.5, 
119.6, 109.5, 63.4, 60.0 (x2), 57.9, 42.0, 33.5, 31.2, 21.4; IR (film, cm-1) ; 
3257, 2942, 2865, 2822, 1729, 1658, 1458, 1330, 1247, 1158, 984, 868, 
816, 745, 662, 605, 544, 522, 509, 507; HRMS (FAB) calcd for 
C23H26N3O5S [M+H]+ 456.1593; Found: m/z 456.1608. 
 Compound 4d: 4d was obtained by following the procedure for 4a: 
[α]D22 –59.9 ° (c 1.03, CHCl3); 1H NMR (CDCl3)  8.01 (1H, d, J = 8.0 Hz), 
7.91 (1H, s), 7.56-7.50 (4H, m), 7.29-7.28 (1H, m), 7.19 (2H, d, J = 8.0 
Hz), 7.02 (1H, d, J = 7.7 Hz), 6.91 (1H, s), 6.79 (1H, d, J = 7.7 Hz), 6.17-
6.11 (1H, m), 5.74 (1H, s), 5.18 (1H, d, J = 10.3 Hz), 5.00 (1H, d, J = 17.2 
Hz), 4.03-3.99 (2H, m), 2.68 (1H, d, J = 14.6 Hz), 2.38 (3H, s), 1.91-1.85 
(1H, m); 13C NMR (126 MHz, CDCl3)  194.5, 174.3, 146.7, 143.3, 141.4, 
141.2, 137.6, 134.9, 133.0, 132.8, 131.0, 129.8, 129.6, 127.2, 126.9, 
124.5, 124.3, 124.0, 118.8, 109.5, 69.3, 66.6, 31.4, 21.5, 14.1; IR (film, 
cm-1) ; 2979, 2913, 1743, 1716, 1541, 1233, 1087, 965, 914, 744; HRMS 
(FAB) calcd for C27H24N3O6S [M+H]+ 518.1386; Found: m/z 518.1381.  
Compound 13: To a solution of 5b (40 mg, 0.105 mmol) in CH2Cl2 (2 
mL) was added tBuOCl (0.018 ml, 0.158 mmol), and the mixture was 
stirred at room temperature for 1 h. Concentration under reduced 
pressure gave the crude material, and used the next reaction without 
purification. To the solution of the residue in EtOH (2 ml) and CH2Cl2 (3 
mL) was added HCl (1 M in Et2O, 0.10 mL), and the mixture was stirred 
at room temperature for 3 h. The reaction mixture was concentrated 
under reduced pressure and purified by flash column chromatography on 
silica gel (20% EtOAc/hexane) to give 13 (28 mg, 73 % ) as a white solid: 
[α]D23 –26.0 ° (c 0.10, CHCl3); 1H NMR (CDCl3)  8.62 (1H, s), 7.54 (2H, d, 
J = 8.0 Hz), 7.17 (3H, t, J = 8.3 Hz), 6.90 (1H, d, J = 7.7 Hz), 6.81 (1H, d, 
J = 7.7 Hz), 5.82-5.74 (2H, m), 5.31 (1H, t, J = 5.2 Hz), 4.76 (1H, t, J = 
8.7 Hz), 4.20-4.17 (1H, m), 3.55-3.50 (2H, m), 2.36 (3H, s), 2.17-2.15 (1H, 
m), 1.49-1.44 (1H, m); 13C NMR (126 MHz, CDCl3)  178.7, 143.2, 140.9, 
137.9, 136.9, 134.9, 129.7, 129.5, 128.3, 127.8, 127.0, 126.9, 122.6, 
120.4, 109.3, 63.0, 46.1, 44.6, 28.5, 21.4 IR (film, cm-1) 3300, 2946, 
2863, 1705, 1617, 1494, 1460, 1404, 1327, 1249, 1196, 1155, 1014, 970, 
946, 908, 855, 809, 781, 727, 710, 659; HRMS (FAB) calcd for 
C20H20N2O3S [M]+ 368.1195; Found: m/z 368.1195. 
Compound 23 (Table 2, entry 5): To a solution of 5d (12.2 mg, 0.0244 
mmol) in CH2Cl2 (2 mL) was added tBuOCl (4.1 L, 0.037 mmol), and the 
mixture was stirred at room temperature for 1 h. Concentration under 
reduced pressure gave the crude material, used the next reaction without 
purification. To the solution of residue in EtOH (2 mL) was added conc. 
HCl (1 L), and the mixture was stirred at room temperature for 30 min. 
Iron (6.8 mg, 0.122 mmol) and water (0.50 mL) were added to the 
solution, and the mixture was refluxed for 3 h. After reaction mixture was 
filtered through a pad of Celite, and concentration under reduced 
pressure. The residue was purified by flash column chromatography on 
silica gel (30% EtOAc/hexane) to give 23 (5.4 mg, 47%) as a colorless 
oil: [α]D23 –32.7 ° (c 0.09, CHCl3); 1H NMR (CDCl3)  9.51 (1H, s), 8.67 
(1H, d, J = 8.3 Hz), 8.01 (1H, d, J = 8.0 Hz), 7.66 (2H, d, J = 8.0 Hz), 
7.41-7.29 (3H, m), 7.11-7.10 (4H, m), 6.09 (1H, s), 5.90-5.84 (1H, m), 
5.20 (1H, d, J = 10.3 Hz), 4.76 (1H, d, J = 16.9 Hz), 4.14 (1H, d, J = 14.0 
Hz), 3.70-3.65 (2H, m), 3.39 (1H, d, J = 15.8 Hz), 2.31 (3H, s); 13C NMR 
(126 MHz, CDCl3)  143.2, 137.8, 137.7, 134.9, 134.2, 133.7, 132.1, 
131.1, 129.5, 128.4, 127.8, 127.0, 124.5, 124.1, 123.3, 123.0, 119.6, 
116.7, 116.4, 115.2, 115.1, 112.9, 64.1, 43.1, 31.2, 21.4; IR(film, cm-1) 
3219, 3153, 3080, 2936, 2855, 1716, 1590, 1493, 1427, 1409, 1377, 
1339, 1283, 1157, 1050, 1015, 795, 749, 706, 665; HRMS (ESI) calcd for 
C27H22N3O3S [M-H]- 468.1387; Found: m/z 468.1374. 
Compound 21: To a solution of 5d (30 mg, 0.060 mmol) in CH2Cl2 (2 
mL) was added tBuOCl (10 L, 0.090 mmol), and the mixture was stirred 
at room temperature for 1 h. Concentration under reduced pressure gave 
the crude material, used the next reaction without purification. To the 
solution of residue in EtOH (4 mL) was added conc. HCl (1 L), and the 
mixture was stirred at room temperature for 30 min. The reaction mixture 
was then quenched with water, extracted with EtOAc, washed with water 
and brine, dried over Na2SO4. After concentration under reduced 
pressure, purification by flash column chromatography on silica gel (40% 
EtOAc/hexane) gave 21 (31.9 mg, 98 %) as a white amorphous: [α]D21 
+42.7 ° (c 0.51, CHCl3); 1H NMR (CDCl3)  7.82 (1H, d, J = 8.0 Hz), 7.52-
7.45 (3H, m), 7.36 (1H, t, J = 7.7 Hz), 7.22-7.16 (4H, m), 7.07 (1H, d, J = 
7.4 Hz), 6.34 (1H, d, J = 7.7 Hz), 5.97-5.91 (1H, m), 5.73 (1H, s), 5.09 
(1H, d, J = 10.6 Hz), 4.90 (1H, d, J = 17.2 Hz), 4.33-4.29 (2H, m), 4.10 
(3H, td, J = 13.1, 5.7 Hz), 2.72-2.70 (1H, m), 2.37 (3H, s), 1.24 (3H, dd, J 






= 14.5, 7.3 Hz); 13C NMR (126 MHz, CDCl3)  194.1, 178.1, 155.6, 147.8, 
143.2, 139.0, 137.8, 134.7, 131.9, 131.54, 131.51, 131.3, 130.0, 129.5, 
126.90, 128.87, 125.2, 124.4, 119.9, 118.2, 68.3, 66.4, 63.8, 41.5, 29.7, 
21.4, 13.7; IR (film, cm-1) 3028, 2938, 2858, 1714, 1695, 1612, 1573, 
1532, 1475, 1434, 1342, 1299, 1245, 1224, 1157, 1012, 882, 845, 813, 
749, 706, 690, 662; HRMS (ESI) calcd for C29H28N3O6S [M+H]+ 
546.1693; Found: m/z 546.1697. 
Compound 22: To a solution of 21 (31.9 mg, 0.0585 mmol) in EtOH (6 
mL) and water (1.5 mL) was added iron (65 mg, 1.16 mmol) and NH4Cl 
(65 mg, 1.21 mmol, purchased from KANTO Chemicals). The mixture 
was refluxed for 1 h. The reaction mixture was then quenched with water, 
extracted with EtOAc, washed with water and brine, dried over Na2SO4. 
After concentration under reduced pressure, purification by flash column 
chromatography on silica gel (50% EtOAc/hexane) gave 22 (11.9 mg, 
43 %) as a white amorphous: [α]D27 +140.7 ° (c 0.12, CHCl3); 1H NMR 
(CDCl3)  7.71 (1H, d, J = 7.7 Hz), 7.50-7.46 (3H, m), 7.30-7.27 (3H, m), 
7.14 (2H, d, J = 8.0 Hz), 7.06-7.03 (2H, m), 6.74-6.67 (1H, m), 5.75 (1H, 
s), 5.35 (1H, d, J = 10.6 Hz), 5.21 (1H, d, J = 17.2 Hz), 3.89-3.86 (1H, m), 
3.46-3.44 (1H, m), 2.42-2.33 (5H, m), 1.72 (1H, t, J = 12.6 Hz); 13C NMR 
(126 MHz, CDCl3)  199.4, 166.6 148.1, 143.2, 141.7, 137.4, 135.5, 
129.6, 129.2, 127.0, 126.6, 126.2, 126.0, 122.3, 120.3, 116.0, 114.6, 
85.0, 61.1, 34.5, 28.2, 21.4; IR (film, cm-1) 3150, 3086, 3040, 2960, 2923, 
2857, 1702, 1630, 1607, 1570, 1476, 1431, 1285, 1325, 1266, 1232, 
1156, 1087, 1019, 990, 910, 875, 813, 741, 668; HRMS (FAB) calcd for 
C27H24N3O3S [M+H]+ 470.1538; Found: m/z 470.1545. 
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The construction of the pentacyclic skeleton of communesins has been investigated 
via the oxidative rearrangement of aurantioclavine derivatives, which are thought to 
be biosynthetic intermediates of the communesins. The C7 quaternary carbon 
center was constructed in a stereoselective manner, whilst the C11 stereocenter 
required an epimerization step. The isolation of 2-ethoxyindolenine prior to the 
reduction of the nitro group and cyclization was critical to the success of the 
strategy. 
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